[1] [1] FOUTS A E, COMOS-AGRAR L, STRNGEL K F, et al. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109［J］. Proceedings of the National Academy of Sciences, 2014, 111(22): 8209-8214.

[2] [2] MANICKLAL S, EMERY V C, LAZZAROTTO T, et al. The “silent” global burden of congenital cytomegalovirus［J］. Clinical Microbiology Reviews, 2013, 26(1): 86-102.

[3] [3] ORNOY A, DIAV-CITRIN O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy［J］. Reproductive Toxicology, 2006, 21(4): 399-409.

[4] [4] DASARI V, SMITH C, KHANNA R. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases［J］. Expert Review of Vaccines, 2013, 12(6): 661-676.

[5] [5] KRAUSE P R, BIALEK S R, BOPPAN S B, et al. Priorities for CMV vaccine development［J］. Vaccine, 2013, 32(1): 4-10.

[6] [6] PASS R F, ZHANG C, EVANS A, et al. Vaccine prevention of maternal cytomegalovirus infection［J］. The New England Journal of Medicine, 2009, 360(12): 1191-1199.

[7] [7] BERNSTEIN D I, MUNOZ F M, CALLAHAN S T, et al. Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls:a randomized clinical trial［J］. Vaccine, 2016, 34(3): 313-319.

[8] [8] CHIUPPESI F, WUSSOW F, JOHNSON E, et al. Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection［J］. Journal of Virology, 2015, 89(23): 11884-11898.

[9] [9] PACHL C, PROBERT W S, HERMSEN K M, et al. The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86［J］. Virology, 1989, 169(2): 418-426.

[10] [10] CUI X, CAO Z, WANG S, et al. Immunization of rabbits with recombinant human cytomegalovirus trimeric versus monomeric gH/gL protein elicits markedly higher titers of antibody and neutralization activity［J］. International Journal of Molecular Sciences, 2019, 20(13): 3158-3172.

[11] [11] DESAI P J, SCHAFFER P A, MINSON A C. Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1:evidence that gH is essential for virion infectivity［J］. Journal of General Virology, 1994, 69(6): 1147-1156.

[12] [12] WANG Xiaoyan, PENG Huiqin. Structure, typing and biological activity of human cytomegalovirus envelope glycoproteins gB and gH［J］. Chinese Journal of Health Inspection, 2008, 18(10): 2175-2177.

[13] [13] MACAGNO A, BERNASCONI N L, VANZETTA F, et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex［J］. Journal of Virology, 2010, 84(2): 1005-1013.

[14] [14] LILLERI D, KABANOVA A, LANZAVECCHIA A, et al. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo［J］. Journal of Clinical Immunology, 2012, 32(6): 1324-1331.

[15] [15] CUI X, FREED D C, WANG D, et al. Impact of antibodies and strain polymorphisms on cytomegalovirus entry and spread in fibroblasts and epithelial cells［J］. Journal of Virology, 2017, 91(13): 1616-1650.

[16] [16] KABANOVA A, PEREZ L, LILLERI D, et al. Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies［J］. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(50): 17965-17970.

[17] [17] GERNA G, PERCIVALLE E, PEREZ L, et al. Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH/gL/pUL128L and trimer gH/gL/gO as well as antibodies elicited during primary HCMV infection prevent epithelial cell syncytium formation［J］. Journal of Virology, 2016, 90(14): 6216-6223.

[18] [18] QUINNAN J G V, DELERY M, ROOK A H, et al. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus［J］. Annals of Internal Medicine, 1984, 101(4): 478-483.

[19] [19] SUN Z, LU Y, RUAN Q, et al. Human cytomegalovirus UL145 gene is highly conserved among clinical strains［J］. Journal of Biosciences, 2007, 32(6): 1111-1118.

[20] [20] BJ R, MA J, DD D, et al. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion［J］. Journal of Virology, 2006, 80(2): 710-722.

[21] [21] SINZGER C, SCHMIDT K, KNAPP J, et al. Modification of human cytomegalovirus tropism through propagation in vitro Sis associated with changes in the viral genome［J］. Journal of General Virology, 1999, 80(11): 2867-2877.

[22] [22] JIN Yinghong, RAN Duoliang, YE Weicheng, et al. Prokaryotic expression and immunoblotting of duck plague virus envelope glycoprotein gH ［J］. Zhejiang Agricultural Science, 2008, 2008(3): 368-371.

[23] [23] JI Chaoneng, BAI Xiaoyang, SHENG Xiaoyu, et al. Subcloning and high expression of heat-resistant alkaline phosphatase FD-TAP removed by signal peptide in Escherichia coli［J］. Journal of Bioengineering, 2000, 16(6): 690-694.

[24] [24] HULST M M, WESTRA D F, WENSVOORT, et al. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera［J］. Journal of Virology, 1993, 67(9): 5435-5442.

[25] [25] PENG T, PONCEDELEON M, JIANG H, et al. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge［J］. Journal of Virology, 1998, 72(1): 65-72.

[26] [26] ZHAO Tingting, XU Ye, LIAO Minjing, et al. Prokaryotic expression of NS1 protein of Zika virus and preparation of monoclonal antibody ［J］. Chinese Journal of Zoonosis, 2019, 35(3): 196-200.

[27] [27] XU Feng, QIU Yilan, QIU Guo, et al. Prokaryotic expression and activity identification of human cytomegalovirus pp65 protein ［J］. Life Science Research, 2013, 17(4): 298-304.